Animal health companies make significant strides in the fight against antibiotic resistance

Over the past 2 years, the animal health industry has created 49 new vaccines and invested $ 10 billion in research and development as part of an initiative to reduce the need for antibiotics.

Animal health companies have invested $ 10 billion in veterinary research and developed 49 new vaccines over the past 2 years, contributing to an industry-wide initiative to help reduce the need for antibiotics.1

The delivery of 100 new vaccines by 2025 was among the 25 commitments made by the world’s largest animal health companies in a Roadmap to reducing the need for antibiotics2 published in 2019 by HealthforAnimals. They are on track or ahead of schedule in each of their commitments, including training over 100,000 veterinarians in the responsible use of antibiotics.1 Animal health companies are strategizing for growth and continually increasing those goals to help reduce the burden of antibiotics.1

“The roadmap is unique in the healthcare industries to set measurable goals and regular updates on our efforts to tackle antibiotic resistance,” said Carel du Marchie Sarvaas, executive director of HealthforAnimals, in a company press release.3

“Few, if any, have set these kinds of traceable goals and progress to date shows how seriously animal health companies take our responsibility to meet this collective challenge, which poses a threat to lives and resources. subsistence in the world, ”he added.

The new vaccines provide increased protection against disease for a range of animal species (i.e. cattle, poultry, pigs, fish, pets), validating that the industry is halfway towards its vaccine target. In addition, these new inoculations are vital to preserve essential medicines for urgent human and animal use, and reduce the risk of developing drug resistance by preventing animal diseases (for example, salmonella, bovine respiratory diseases, infectious bronchitis) which might otherwise lead to antibiotic treatment.

In addition, the sector has launched a series of prevention products to limit livestock diseases. It also produced 17 new diagnostic tools out of a target of 20 for the earlier prevention, detection and treatment of disease, and 7 nutritional supplements that support the immune system.1

In addition, the industry has developed 3 new antibiotics during the same period, demonstrating the priority investment in creating products that prevent disease and the need for antibiotics, to begin with. The industry has also helped train over 650,000 veterinary professionals and provided over $ 6.5 million in scholarships to veterinary students over the past 2 years.3

The following Roadmap to reducing the need for antibiotics progress report is expected in 2023.

The references

  1. Reports: roadmap progress report. Animal health. Accessed November 18, 2021. https://www.healthforanimals.org/reports/roadmap-progress-report-2021/
  2. Roadmap to reducing the need for antibiotics. Animal health. Accessed November 18, 2021. https://www.healthforanimals.org/roadmap/
  3. Animal health companies ahead of schedule to meet 25 target commitments to help fight antibiotic resistance. Press release. Animal health. November 17, 2021. Accessed November 18, 2021.


Source link

Boyd S. Abbott